MedTrace Logo

Effectiveness of TCC Followed by MBCT and Predictive Factors (Genetic, Clinical and Cognitive) Response

NCT02472483 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2019-11-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether a Cognitive and Behavioral group Therapy (CBT) + Mindfulness Based Cognitive Therapy (MBCT) decreased relapses and hospitalizations and improved outcomes (depressive and manic symptoms, self-esteem, and quality of life) in a large sample of refractory bipolar I patients on mood stabilizers.

Conditions

Interventions

BEHAVIORAL

Cognitive and Behavior Therapy (CBT)

20-weeks CBT

BEHAVIORAL

Mindfulness Based Cognitive Therapy (MBCT)

8-weeks MBCT

Sponsors & Collaborators

  • Centre Hospitalier St Anne

    lead OTHER

Principal Investigators

  • Philip GORWOOD, MD., PhD · Centre Hospitalier Sainte-Anne

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-13
Primary Completion
2019-09-13
Completion
2019-09-13

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02472483 on ClinicalTrials.gov